One Capital Management, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
One Capital Management, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$384,865
+5.9%
10,0750.0%0.02%
+6.2%
Q2 2023$363,405
-5.6%
10,0750.0%0.02%
-15.8%
Q1 2023$384,764
-32.9%
10,0750.0%0.02%
-38.7%
Q4 2022$573,267
+18.9%
10,075
-17.4%
0.03%
+10.7%
Q3 2022$482,000
-10.1%
12,2000.0%0.03%
-12.5%
Q2 2022$536,000
+10.3%
12,2000.0%0.03%
+23.1%
Q1 2022$486,000
-0.8%
12,2000.0%0.03%
-29.7%
Q4 2021$490,000
-1.4%
12,200
-0.2%
0.04%
-9.8%
Q3 2021$497,000
-54.8%
12,229
-49.5%
0.04%
-58.2%
Q2 2021$1,100,00024,2290.10%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders